Tag: Susvimo

Explore our medication guides and pharmacology articles within this category.

Answering the Question: Why was Susvimo recalled?

Oct 9, 2025 •

4 min read

In October 2022, Genentech voluntarily recalled its Susvimo ocular implant, a novel treatment for wet age-related macular degeneration (AMD), just a year after its FDA approval. The recall was initiated after some implants failed quality performance standards during testing, providing the definitive answer to **why was Susvimo recalled**.

Is Susvimo FDA-approved? Understanding the Approval, Recall, and Reintroduction

Oct 9, 2025 •

3 min read

Susvimo was first FDA-approved in October 2021 for wet age-related macular degeneration, but a voluntary recall in 2022 due to manufacturing issues created a temporary hurdle. Today, following a successful relaunch in 2024, Susvimo is not only FDA-approved but also carries multiple indications for treating serious retinal conditions.